GT

Ghost Tree Capital, LLC

Diversified strategySector-focusedQuality / disciplined sizing

Total reported value

$331.0M

Reporting period: 2024-09-30 · Number of holdings: 54

Ghost Tree Capital, LLC disclosed 54 holdings in its latest 13F filing for the period ending 2024-09-30, with total reported value of $331.0M and a quarterly turnover rate of 0.0%.

Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "G"

Personality snowflake

Concentration
12.6
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
100
Diversification
100
Sizing Uniformity
91.94

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 52 holdings (of 54 total)

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1XBISs Spdr S&p Biotech ETFETF-Tech8.95%——
2✓ Biohaven LTDStock-Other5.26%——
3SRPTSarepta Therapeutics INCStock-Healthcare4.53%—+118.18%
4NVONovo-nordisk A/s-spons AdrStock-Healthcare3.96%——
52655787DBlueprint Medicines CORPStock-Other3.91%—+250.00%
6AXSMAxsome Therapeutics INCStock-Healthcare3.66%—-10.00%
7TARSTarsus Pharmaceuticals INCStock-Other3.48%—+48.94%
8CATXPerspective Therapeutics INCStock-Other3.02%—-18.92%
9CGONCg Oncology INCStock-Other2.85%—-3.85%
10ROIVRoivant Sciences Ltd.Stock-Healthcare2.79%—-20.00%
11PCVXVaxcyte INCStock-Other2.76%—-46.67%
12INSMInsmed INCStock-Healthcare2.76%—-52.83%
13VKTXViking Therapeutics INCStock-Healthcare2.68%—+47.37%
14SNDXSyndax Pharmaceuticals INCStock-Other2.62%—+28.57%
15JANXJanux Therapeutics INCStock-Other2.61%—+280.00%
16CRBPCorbus Pharmaceuticals HoldiStock-Other2.37%—+117.14%
17ASNDAscendis Pharma A/SStock-Other2.37%—-39.46%
18CRNXCrinetics Pharmaceuticals InStock-Other2.32%—-37.50%
19SLNOEURSoleno Therapeutics INCStock-Other2.29%—-50.00%
20TGTXTg Therapeutics INCStock-Healthcare2.19%—-38.00%
21RZLTRezolute INCStock-Other2.16%—+3.76%
22PHATPhathom Pharmaceuticals INCStock-Other2.05%—-37.50%
23MLTXMoonlake ImmunotherapeuticsStock-Other1.96%—-57.20%
24OLMAOlema Pharmaceuticals INCStock-Other1.93%—-2.73%
25IMVTImmunovant INCStock-Other1.85%—-17.31%
26EWTXEdgewise Therapeutics INCStock-Other1.57%——
27REPLReplimune Group INCStock-Other1.49%——
28BBIOBridgebio Pharma INCStock-Healthcare1.35%—+25.00%
29TSHATaysha Gene Therapies INCStock-Other1.31%—+72.00%
30RYTMRhythm Pharmaceuticals INCStock-Other1.25%—-32.84%
31ANNXAnnexon INCStock-Other1.16%—+23.93%
32KRROKorro Bio INCStock-Other1.11%—+10.00%
33DYNDyne Therapeutics INCStock-Other1.09%——
34ARVNArvinas INCStock-Other1.08%—+93.33%
35✓ Helix Acquisition CORP IiStock-Other0.95%——
36NUVBNuvation Bio INCStock-Other0.93%—+17.39%
37SVRASavara INCStock-Other0.93%—-31.01%
38TNYATenaya Therapeutics INCStock-Other0.87%—+11.11%
39RGNXRegenxbio INCStock-Other0.84%—+55.88%
40CRVSCorvus Pharmaceuticals INCStock-Other0.80%——
41ABSIAbsci CORPStock-Other0.63%——
42NGNENeurogene INCStock-Other0.63%—-28.57%
43CAPRCapricor Therapeutics INCStock-Other0.57%——
44APLSUSDApellis Pharmaceuticals INCStock-Other0.57%—-51.85%
45SMMTSummit Therapeutics INCStock-Other0.56%——
46SYRESpyre Therapeutics INCStock-Other0.53%—-76.02%
47VRDNViridian Therapeutics INCStock-Other0.52%—-87.24%
48✓ Proqr Thrapeutics N VStock-Other0.49%—-1.37%
49ATYRAtyr Pharma INCStock-Other0.43%——
50LRMRLarimar Therapeutics INCStock-Other0.40%——
1–50 of 52

Holding changes this quarter

Position changes disclosed by Ghost Tree Capital, LLC for the quarter ending 2024-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Ghost Tree Capital, LLC and what type of investor is it?
Ghost Tree Capital, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2024-09-30), the firm manages a tracked equity portfolio valued at approximately $331.0M, spread across 54 disclosed positions.
What are Ghost Tree Capital, LLC's largest equity positions?
Based on the latest 13F filing, Ghost Tree Capital, LLC's top holdings by market value are: 1. Ss Spdr S&p Biotech ETF (XBI) — $29.6M (8.9%) 2. Biohaven LTD — $17.4M (5.3%) 3. Sarepta Therapeutics INC (SRPT) — $15.0M (4.5%) 4. Novo-nordisk A/s-spons Adr (NVO) — $13.1M (4.0%) 5. Blueprint Medicines CORP (2655787D) — $13.0M (3.9%)
What changes did Ghost Tree Capital, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Ghost Tree Capital, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Ghost Tree Capital, LLC focus on?
Ghost Tree Capital, LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%

Peer Institutions

Institutions with a similar AUM

FP

Fiduciary Planning LLC

Total reported value

$331.1M

76 stks

2026-03-31

Concentration22.7
Portfolio Stability9.3
Sector conviction84.6

AUM within 0.0% of this institution

View detail
QF

Quattro Financial Advisors LLC

Total reported value

$330.9M

91 stks

2026-03-31

Concentration11.4
Portfolio Stability32.1
Sector conviction76.3

AUM within 0.0% of this institution

View detail
HL

Hidden Lake Asset Management LP

Total reported value

$330.9M

28 stks

2026-03-31

Concentration33.3
Portfolio Stability100.0
Sector conviction100.0

AUM within 0.1% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

JF

Jefferies Financial Group Inc.

Total reported value

$14.6B

1,692 stks

2026-03-31

Concentration26.7
Portfolio Stability90.5
Sector conviction39.6

1 of the top 5 holdings overlap, including Ss Spdr S&p Biotech ETF

View detail
M&

Marvin & Palmer Associates INC

Total reported value

$83.5M

21 stks

2026-03-31

Concentration21.6
Portfolio Stability90.7
Sector conviction62.0

1 of the top 5 holdings overlap, including Ss Spdr S&p Biotech ETF

View detail
LM

Legg Mason Investment Counsel & Trust Co., N.A.

Total reported value

$522.2M

503 stks

2014-09-30

Concentration4.0
Portfolio Stability12.3
Sector conviction53.9

1 of the top 5 holdings overlap, including Novo-nordisk A/s-spons Adr

View detail